Cohort study on the Effect of various nicotine consumption modalities on Mohs surgery complications.
Study Goal
The researchers aimed to evaluate the impact of various nicotine consumption modalities on complication rates after Mohs micrographic surgery (MMS).
Results Summary
Patients with any history of nicotine use had an 8.5% absolute risk of complications compared to 3.1% for non-users, representing a relative risk of 2.75. Smoked tobacco use was a statistically significant factor for complications, while risks from smokeless nicotine products remain unclear.
Population
404 patients undergoing Mohs micrographic surgery (MMS).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Cigarette smoking | decrease | outcomes | - | - | is known to adversely affect | #1 |
any history of nicotine use | increase | complications | MMS patients | 8.5% absolute risk | had an 8.5% absolute risk of experiencing | #2 |
no history of nicotine use | increase | complications | MMS patients | 3.1% | had a risk of | #3 |
any history of nicotine use | increase | complications | MMS patients | 2.75 | representing a relative risk of | #4 |
past smoked tobacco use | increase | complications | MMS patients | - | found as statistically significant factors for | #5 |
smoked tobacco | increase | complication following MMS | patients | - | appear to be at a significantly increased risk of experiencing | #6 |
Knowledge on the effect of different nicotine consumption modalities on dermatologic surgical outcomes is limited, with conflicting conclusions. Cigarette smoking is known to adversely affect outcomes, but the impact of other nicotine consumption modalities like cigars, smokeless tobacco, and nicotine replacement therapy (NRT) is less understood. Our objective was to evaluate the impact of various nicotine consumption modalities on complication rates after Mohs micrographic surgery (MMS). We conducted a prospective cohort study of 404 MMS patients. Variables analyzed included patient age, sex, post-operative complications, and nicotine history via a questionnaire. We found that patients with any history of nicotine use had an 8.5% absolute risk of experiencing complications while the risk for patients without a history of nicotine use was 3.1%, representing a relative risk of 2.75. Cox proportional hazard testing found patient sex and past smoked tobacco use as statistically significant factors for complications. Patients who have smoked tobacco appear to be at a significantly increased risk of experiencing a complication following MMS compared to never-nicotine users. Larger studies are needed to clarify the surgical risks posed by smokeless nicotine products.